Valganciclovir Powder, For Solution
Product Images NDC 46708-754

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 46708-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-t1-formula.jpg (Valganciclovir T1 Formula)

Text panel displaying medical calculation formulas for Mosteller Body Surface Area (BSA) and Schwartz Creatinine Clearance. The formulas use height, weight, and serum creatinine values to calculate respective medical parameters.*

FDA Label Image

Valganciclovir-t2-formula.jpg (Valganciclovir T2 Formula)

Panel showing formula for calculating a value using age, body weight, and serum creatinine. Separate calculation for males and females is provided; female value is 0.85 times the male value. Units include years, kilograms, and mg/dL for serum creatinine.*

FDA Label Image

Valganciclovir-str.jpg (Valganciclovir Str)

Chemical structure of Valganciclovir hydrochloride, the active ingredient shown as a molecular diagram with atoms and bonds depicting its chemical composition.*

FDA Label Image

Valganciclovir-figr1.jpg (Valganciclovir Figr1)

An instructional diagram depicting the components of a bottle and an oral dispenser used for liquid medication. The bottle is shown with a child-resistant cap, bottle adapter, and the bottle itself. The oral dispenser includes labeled parts: plunger, barrel with volume markings, and tip.*

FDA Label Image

Valganciclovir-step-1.jpg (Valganciclovir Step 1)

An instructional line drawing showing a hand holding a bottle with the instruction 'Shake well' and arrows indicating the motion. This illustration demonstrates how to shake the bottle, likely for the preparation of Valganciclovir oral powder for solution.*

FDA Label Image

Valganciclovir-step-2.jpg (Valganciclovir Step 2)

An instructional line drawing showing a bottle with a cap being screwed on or off, indicated by an arrow pointing downwards and a curved arrow suggesting twisting motion, likely illustrating how to open or close the bottle.*

FDA Label Image

Valganciclovir-step-3.jpg (Valganciclovir Step 3)

An illustration showing an oral syringe with volume markings from 2 mL to 10 mL. The image highlights a dosage indicator for measuring liquid medication volume in milliliters.*

FDA Label Image

Valganciclovir-step-4.jpg (Valganciclovir Step 4)

An instructional line drawing showing one hand holding a syringe and another hand pressing down the plunger. The drawing emphasizes the action of pushing the plunger down, indicated by an arrow pointing downward above the plunger.*

FDA Label Image

Valganciclovir-step-5.jpg (Valganciclovir Step 5)

An instructional line drawing showing a hand holding a syringe being inserted into the bottle adapter opening of a medicine bottle. The image illustrates how to use the syringe to draw liquid from the bottle.*

FDA Label Image

Valganciclovir-step-6.jpg (Valganciclovir Step 6)

An instructional diagram showing how to draw liquid medicine from a bottle into a syringe. The bottle is held upside down, and the syringe is positioned below the bottle opening, with volume markings visible on the syringe barrel from 2 mL to 10 mL.*

FDA Label Image

Valganciclovir-step-7.jpg (Valganciclovir Step 7)

An instructional line drawing illustrating a hand using a syringe or dosing device to withdraw liquid from an open bottle, likely demonstrating how to measure and prepare an oral solution from the Valganciclovir powder for solution bottle.*

FDA Label Image

Valganciclovir-step-8.jpg (Valganciclovir Step 8)

An illustration depicting the administration of oral medication to a child using a syringe. The syringe is shown being placed into the child's mouth for dosing, indicating a method for giving oral liquid medicine.*

FDA Label Image

Valganciclovir-step-9.jpg (Valganciclovir Step 9)

An instructional diagram showing a medication bottle with a child-resistant safety cap indicated by an arrow illustrating the direction to turn the cap to open the bottle.*

FDA Label Image

Valganciclovir-step10-1.jpg (Valganciclovir Step10 1)

An instructional illustration showing a water faucet dripping water onto a syringe and a small cup held beneath it. The image likely depicts rinsing or preparation steps for an oral solution.*

FDA Label Image

Valganciclovir-step10-2.jpg (Valganciclovir Step10 2)

Illustration showing a medical syringe with graduated measurement markings, including a plunger and a nozzle tip. The syringe is empty and depicted in a side view.*

FDA Label Image

50 mg Per mL (Valganciclovir 50 mg Bottle)

Label for Valganciclovir for Oral Solution, USP, 50 mg/mL, powder for solution, in a 100 mL (3.4 fl oz) bottle. Manufactured by Alembic Pharmaceuticals Limited, with instructions for storage and use, including keeping the powder dry and the solution refrigerated. Includes NDC 46708-754-31 and dosing/handling information.*

FDA Label Image

50 mg Per mL (Valganciclovir50mg Carton)

Packaging label for Valganciclovir for Oral Solution, USP 50 mg/mL powder for solution, oral use. The label indicates a 100 mL (3.4 fl oz) carton by Alembic Pharmaceuticals Limited. The label includes the NDC 46708-754-31, dosage strength, usage instructions, manufacturer information, and a barcode on one side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.